Evaluation of the Effect of Itraconazole, Quinidine and Rifampicin on the Single-Dose Pharmacokinetics of ZED1227
CEC-012/BIO
Phase 1 other active
Quick answer
Evaluation of the Effect of Itraconazole, Quinidine and Rifampicin on the Single-Dose Pharmacokinetics of ZED1227 for No medical condition. is a Phase 1 program (other) at Dr. Falk Pharma GmbH with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Dr. Falk Pharma GmbH
- Indication
- No medical condition.
- Phase
- Phase 1
- Modality
- other
- Status
- active